HEMODİYALİZDE TÜNELLİ KATETERLER

Amaç: Bu çalışmada hemodiyaliz hastalarındakullanılan tünelli kateterlerin erken ve geçdönem komplikasyonları ve açık kalımoranlarını değerlendirmeyi amaçladık.Materyal ve Metod: Kliniğimizde ocak 2010-mart 2012 tarihleri arasında 181 kalıcı tünellikateter takılan 154 hasta yaş, cinsiyet, katetertakma endikasyonu, katater uygulama yerleri,çıkartılma sebepleri ve komplikasyonlaraçısından retrospektif olarak incelendi.Bulgular: Kalıcı tünelli kateter takılmanedenleri; hastaların % 62.3 (n=96) ü başarısızarterio-venöz fistül (AVF) girişimleri, % 24(n=37) 37 (%24) si AVF maturasyonununbeklenmesi, % 7.7 (n=12) si kısa yaşambeklentisi, % 5.8 (n=9) i hasta tercihindendolayı idi. Kateter yerleştirme yerleri ise;hastaların % 83.1 (n=128) ine sağ internaljuguler vene, % 10.3 (n=16) üne sol internaljuguler vene, % 3.2 (n=4) 5 (%3.2) sine solsubclavian vene, % 3.2 (n=5) sine femoralvene kateter takıldı. Takılan tünelli kalıcıhemodiyaliz kateterlerin 2 yıllık takiplerindekatater açık kalım oranılarının 1 yıllık % 86.7,2 yıllık ise %82.4 olarak saptandı.Sonuç: Sonuç olarak kalıcı tünelli hemodiyalizkateterleri, yüksek işlem başarısına ve düşükerken dönem komplikasyonlarına sahip,işlemden hemen sonra diyalize girebilmeimkanı sağlayan, diyaliz için yeterli kanakımını sağlayan yaşam beklentisi kısa olan vetransplantasyon adayları ve AVF için uygunvasküler yapıları olmayan hastalar için ilktercih edilmesi gereken bir damar erişimseçeneğidir.

Tunneled Catheters in Hemodialysis

Aim: In this study, we aimed to evaluate, survival, and early and late complications of indwelling tunneled hemodialysis catheters used in hemodialysis patients. Material and Method: In our clinic, 154 patients catheters were retrospectively analyzed in terms of age, gender, indications for catheter, site of application, reasons for removal and complications between January 2010 and March 2012. Results: insertion causes as follows; 62.3% of patients (n = 96) had failed arteriovenous fistula (AVF) attempts, 24% (n = 37) 37 (24%) had waiting time for AVF maturation, 7.7% (n = 12) had a short life expectancy, 5.8% (n = 9) was because of patient’s preference. Tunelled hemodialysis catheter is inserted; in 83.1% (n = 128) of patients in right internal jugular vein, in 10.3% (n = 16) of patients in left internal jugular vein, in 3.2% (n = 4), 5 (3.2%) was left subclavian vein, 3.2% (n = 5) was femoral vein. catheters survival rate was 86.7% in 1 year follow-up and 82.4% in the second year for 2year follow-up duration. Conclusion: As a result, permanent tunnelled hemodialysis catheters are first preference for vascular access; because of high procedural success possibility of early use after operation, providing dialysis sufficient blood flow, allowing life expectancy is short and transplant candidates and the patient with not suitable vascular structures for AVF

___

  • 2009 Annual Data Report: Atlas of chronic kidney disease and end – stage renal disease in
  • the United States. Am J Kidney Dis. 2010;55:S266–7.
  • Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J
  • Kidney Dis.2006;48:S248–73.
  • Varughese S, John GT, Alexander S, Deborah MN, Nithya N, Ahamed I, et al. Pre-tertiary
  • hospital care of patients with chronic kidney disease in India. Indian J Med
  • Res. 2007;126:28–33.
  • Denys BG, Uretsky BF. Anatomical variations of internal jugular vein location: Impact on
  • central venous access. Crit Care Med. 1991;19:1516–9.
  • Denys BG, Uretsky BF, Reddy PS. Ultrasound-assisted cannulation of the internal jugular
  • vein.A prospective comparison to the external landmark-guided
  • technique. Circulation. 1993;87:1557–62.
  • Molinari AC, Haupt R, Saracco P, Di Marco M, Castagnola E, Fratino G. Urokinase for
  • restoring patency of malfunctioning or blocked central venous catheters in children with
  • hemato-oncological diseases. Support Care Cancer. 2004;12:840–3.
  • Fry AC, Stratton J, Farrington K, Mahna K, Selvakumar S, Thompson H, et al. Factors
  • affecting long-term survival of tunnelled haemodialysis catheters-a prospective audit of 812
  • tunnelled catheters. Nephrol Dial Transplant. 2008;23:275–81.
  • Quarello F, Forneris G, Borca M, Pozzato M. Do central venous catheters have advantages
  • over arteriovenous fistulas or grafts? J Nephrol. 2006;19:265–79.
  • Mandolfo S, Galli F, Costa S, Ravani P, Gaggia P, Imbasciati E. Factors influencing
  • permanent catheter performance. J Vasc Access. 2001;2:106–9.
  • O’Dwyer H, Fotheringham T, O’Kelly P, Doyle S, Haslam P, McGrath F, et al. A
  • prospective comparison of two types of tunneled hemodialysis catheters: The Ash Split versus
  • the PermCath.Cardiovasc Intervent Radiol. 2005;28:23–9.
  • Rao M, Juneja R, Shirly RB, Jacob CK. Haemodialysis for end-stage renal disease in
  • Southern India--a perspective from a tertiary referral care centre. Nephrol Dial
  • Transplant. 1998;13:2494–500.
  • Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J. for the CHOICE study.
  • Type of vascular access and survival among incident hemodialysis patients: The Choices for
  • Healthy Outcomes In Caring ESRD (CHOICE) study. J Am Soc Nephrol. 2005;16:1449–55.